Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.81 USD | +5.09% | +24.04% | +59.11% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 69.72M |
---|---|---|---|---|---|
Net income 2024 * | -23M | Net income 2025 * | -28M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-3.19
x | P/E ratio 2025 * |
-3.44
x | Employees | 21 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.97% |
Latest transcript on Lantern Pharma Inc.
1 day | +5.09% | ||
1 week | +24.04% | ||
Current month | +33.53% | ||
1 month | -12.24% | ||
3 months | +60.99% | ||
6 months | +82.57% | ||
Current year | +59.11% |
Managers | Title | Age | Since |
---|---|---|---|
Panna Sharma
CEO | Chief Executive Officer | 53 | 18-06-30 |
David Margrave
DFI | Director of Finance/CFO | 64 | 18-05-31 |
Reggie Ewesuedo
CTO | Chief Tech/Sci/R&D Officer | - | 23-03-01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Panna Sharma
CEO | Chief Executive Officer | 53 | 18-06-30 |
Director/Board Member | 73 | 22-06-07 | |
Donald Keyser
CHM | Chairman | 71 | 17-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 6.48 | +0.93% | 56,842 |
24-05-07 | 6.42 | -6.28% | 108,571 |
24-05-06 | 6.85 | +11.38% | 156,751 |
24-05-03 | 6.15 | +12.02% | 189,711 |
24-05-02 | 5.49 | +1.86% | 137,628 |
Delayed Quote Nasdaq, May 09, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+59.11% | 69.72M | |
+23.37% | 46.71B | |
+48.83% | 41.8B | |
-0.94% | 41.52B | |
-5.86% | 29.55B | |
+11.29% | 25.78B | |
-20.92% | 19.26B | |
+3.20% | 12.14B | |
-2.67% | 12.08B | |
+30.23% | 11.98B |
- Stock Market
- Equities
- LTRN Stock